Homocysteine as a predictor of apnea-hypopnea index in obstructive sleep apnea: a longitudinal epidemiological study (EPISONO)
- PMID: 38568296
- DOI: 10.1007/s00405-024-08614-z
Homocysteine as a predictor of apnea-hypopnea index in obstructive sleep apnea: a longitudinal epidemiological study (EPISONO)
Abstract
Background: Obstructive sleep apnea (OSA) affects nearly 1 billion people globally, and has established links with cardiovascular and neurocognitive complications. Although it has some limitations, the apnea-hypopnea index (AHI) is commonly used to gauge OSA severity and therapeutic response. Homocysteine (Hcy) metabolism, when impaired, can elicit cellular senescence mechanisms that may be shared with OSA. Hence, our objective was to explore the role of Hcy concentrations both as a predictor of AHI values and as a potential risk factor for OSA.
Methods: Involving 1042 volunteers aged 20 to 80 years, the initial study (2007) included polysomnographic evaluations, questionnaires on sleep and general health, as well as biochemical analyses. After an 8-year interval, 715 participants from the initial study were invited for a follow-up assessment in 2015.
Results: Our findings showed that Hcy was a predictor for an increased AHI, and AHI increased over time. Individuals with plasma Hcy concentrations ≥ 15 µmol/L experienced an average AHI increase of 7.43 events/hour ([beta coefficient] β = 7.43; 95%CI 2.73 to 12.13) over time, compared to those with plasma concentrations < 10 µmol/L. A similar trend was apparent in those with plasma Hcy concentrations between 10 ≥ and < 15 µmol/L, who had an AHI increase with an average beta coefficient of 3.20 events/hour (95%CI 1.01 to 5.39) compared to those with plasma Hcy concentrations < 10 µmol/L.
Conclusions: In summary, our study suggests that increased plasma Hcy concentrations could be considered a risk factor for the development of OSA. These findings highlight that elevated plasma Hcy concentrations can predict the severity of OSA, underscoring their correlation with the AHI.
Keywords: Apnea–hypopnea index; Homocysteine; Sleep.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
[Plasma homocysteine levels in ischemic stroke patients with obstructive sleep apnea].Zhonghua Yi Xue Za Zhi. 2011 Jul 5;91(25):1753-6. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093733 Chinese.
-
Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.J Am Heart Assoc. 2020 Apr 21;9(8):e015013. doi: 10.1161/JAHA.119.015013. Epub 2020 Apr 16. J Am Heart Assoc. 2020. PMID: 32297565 Free PMC article.
-
Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome?J Craniomaxillofac Surg. 2015 Jul;43(6):879-82. doi: 10.1016/j.jcms.2015.03.031. Epub 2015 Apr 3. J Craniomaxillofac Surg. 2015. PMID: 25957103
-
Intra-night variation in apnea-hypopnea index affects diagnostics and prognostics of obstructive sleep apnea.Sleep Breath. 2020 Mar;24(1):379-386. doi: 10.1007/s11325-019-01885-5. Epub 2019 Jul 11. Sleep Breath. 2020. PMID: 31297715 Free PMC article.
-
Association between Serum Homocysteine Level and Obstructive Sleep Apnea: A Meta-Analysis.Biomed Res Int. 2017;2017:7234528. doi: 10.1155/2017/7234528. Epub 2017 Jul 31. Biomed Res Int. 2017. PMID: 28831396 Free PMC article. Review.
References
-
- Sullivan F (2016) Hidden health crisis costing America billions. Underdiagnosing and undertreating obstructive sleep apnea draining healthcare system. American Academy of Sleep Medicine.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical